Skip to main content

Propafenone Hydrochloride Capsule, Extended Release Shortage

Last Updated: May 14, 2025
Status: Discontinued

To Be Discontinued:

Propafenone Hydrochloride, Capsule, Extended Release, 225 mg (Upsher-Smith Laboratories, LLC)

NDC Code: 0832-0740-60
Status: To Be Discontinued
Date of update: May 14, 2025
Update type: New
Related Information: A business decision was made to discontinue the product.
Therapeutic category: Cardiovascular
Date discontinued: May 14, 2025
Initial posting date: May 14, 2025
Contact info: 800-654-2299

Propafenone Hydrochloride, Capsule, Extended Release, 325 mg (Upsher-Smith Laboratories, LLC)

NDC Code: 0832-0741-60
Status: To Be Discontinued
Date of update: May 14, 2025
Update type: New
Related Information: A business decision was made to discontinue the product.
Therapeutic category: Cardiovascular
Date discontinued: May 14, 2025
Initial posting date: May 14, 2025
Contact info: 800-654-2299

Propafenone Hydrochloride, Capsule, Extended Release, 425 mg (Upsher-Smith Laboratories, LLC)

NDC Code: 0832-0742-60
Status: To Be Discontinued
Date of update: May 14, 2025
Update type: New
Related Information: A business decision was made to discontinue the product.
Therapeutic category: Cardiovascular
Date discontinued: May 14, 2025
Initial posting date: May 14, 2025
Contact info: 800-654-2299

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer